Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor

被引：28

作者：

Fernandez-Galar, M

España, A

López-Picazo, JM

机构：

[1] Univ Navarra Clin, Dept Dermatol, Pamplona 31080, Spain

[2] Univ Navarra Clin, Dept Oncol, Pamplona, Spain

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2004年 / 29卷 / 02期

关键词：

D O I：

10.1111/j.1365-2230.2004.01466.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Drugs that inhibit the epidermal growth factor receptor, such as ZD1839 or C225, are being used increasingly in the treatment of solid tumours. This has led to the appearance of new secondary effects. We describe the case of a patient who presented with an acneiform eruption secondary to the administration of ZD1839. These lesions healed in a few days after stopping the drug.

引用

页码：138 / 140

页数：3

共 14 条

[1] Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition [J].

Albanell, J ;

Rojo, F ;

Averbuch, S ;

Feyereislova, A ;

Mascaro, JM ;

Herbst, R ;

LoRusso, P ;

Rischin, D ;

Sauleda, S ;

Gee, J ;

Nicholson, RI ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :110-124

[2] ZD1839 ('Iressa')1,2 as an anticancer agent [J].

Baselga, J ;

Averbuch, SD .

DRUGS, 2000, 60 (Suppl 1) :33-40

[3]

Ben-Bassat H, 2001, Curr Opin Investig Drugs, V2, P1539

[4] Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].

Busam, KJ ;

Capodieci, P ;

Motzer, R ;

Kiehn, T ;

Phelan, D ;

Halpern, AC .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176

[5]

DOORN RV, 2002, BRIT J DERMATOL, V147, P598

[6]

Hansen LA, 2000, CANCER RES, V60, P3328

[7]

Hansen LA, 1997, AM J PATHOL, V150, P1959

[8] Severe acute interstitial pneumonia and gefitinib [J].

Inoue, A ;

Saijo, Y ;

Maemondo, M ;

Gomi, K ;

Tokue, Y ;

Kimura, Y ;

Ebina, M ;

Kikuchi, T ;

Moriya, T ;

Nukiwa, T .

LANCET, 2003, 361 (9352) :137-139

[9]

Jost M, 2000, EUR J DERMATOL, V10, P505

[10]

KIMSAYASADI A, 2002, ARCH DERMATOL, V138, P129

← 1 2 →